Literature DB >> 29336750

Percutaneous versus Cut-Down Technique for Indwelling Port Placement.

Mario Matiotti-Neto, Mariam F Eskander, Omidreza Tabatabaie, Gyulnara Kasumova, Lindsay A Bliss, Sing Chau Ng, Nicholas E Tawa, Blanche Murphy, Jonathan F Critchlow, Jennifer F Tseng.   

Abstract

The superiority of surgical cut-down of the cephalic vein versus percutaneous catheterization of the subclavian vein for the insertion of totally implantable venous access devices (TIVADs) is debated. To compare the safety and efficacy of surgical cut-down versus percutaneous placement of TIVADs. This is a single-institution retrospective cohort study of oncologic patients who had TIVADs implanted by 14 surgeons. Primary outcomes were inability to place TIVAD by the primary approach and postoperative complications within 30 days. Multivariate analysis was performed by logistic regression. Secondary outcomes included operative time. Two hundred and forty-seven (55.9%) percutaneous and 195 (44.1%) cephalic cut-down patients were identified. The 30-day complication rate was 5.2 per cent: 14 patients (5.7%) in the percutaneous and nine (4.6%) in the cut-down group. The technique was not a significant predictor of having a 30-day complication (odds ratio = 0.820; 95% confidence interval 0.342-1.879). Implantation failure was observed in 16 percutaneous patients (6.5%) and 28 cut-down patients (14.4%) (adjusted odds ratio for cephalic vs cut-down = 2.387; 95% confidence interval 1.275-4.606). The median operative time for percutaneous patients was 46 minutes (interquartile range = 35, 59) versus 37.5 minutes (interquartile range = 30, 49) for cut-down patients(P < 0.0001). Both the percutaneous and cut-down technique are safe and effective for TIVAD implantation. Operative times were shorter and the odds of implantation failure higher for cephalic cut-down. As implantation failure is common, surgeons should familiarize themselves with both techniques.

Entities:  

Mesh:

Year:  2017        PMID: 29336750

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents.

Authors:  Keisuke Obuchi; Ken Imaizumi; Hiroyuki Kasajima; Michihiro Kurushima; Minoru Umehara; Yousuke Tsuruga; Daisuke Yamana; Kentaro Sato; Aya Sato; Shinsaku Suzuki; Kazuaki Nakanishi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Cephalic Vein Cut-down for Totally Implantable Central Venous Access Devices With Preoperative Ultrasonography by Surgical Residents.

Authors:  Shintaro Hashimoto; Ryota Otsubo; Masahiro Adachi; Ryoichiro Doi; Kenichiro Shibata; Isao Sano; Yoshihito Shibata; Takayuki Nakazaki; Hideki Taniguchi; Takeshi Nagayasu
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

3.  Arm port vs chest port: a systematic review and meta-analysis.

Authors:  Guanhua Li; Yu Zhang; Hongmin Ma; Junmeng Zheng
Journal:  Cancer Manag Res       Date:  2019-07-03       Impact factor: 3.989

4.  Outcome Comparison of Totally Implantable Venous Access Device Insertions Between Surgeons and Radiologists in Australia.

Authors:  Darius Dastouri; William T McSweeney; Matthew Leaning; Rasika Hendahewa
Journal:  Cureus       Date:  2022-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.